Gastrin and EGF synergistically induce cyclooxygenase-2 expression in Swiss 3T3 fibroblasts that express the CCK2 receptor

Journal of Cellular Physiology

Volumn 196, Issue 3, 2003, Pages 454-463

  Slice, Lee W ^a,b   Hodikian, Raffi ^a   Zhukova, Elena ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 (2,3 DIHYDRO 1 METHYL 2 OXO 5 PHENYL 1H 1,4 BENZODIAZEPIN 3 YL) 3 (3 METHYLPHENYL)UREA; CHOLECYSTOKININ B RECEPTOR; CHOLECYSTOKININ RECEPTOR; CYCLOHEXIMIDE; CYCLOOXYGENASE 2; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; GASTRIN; L 364714; MITOGEN ACTIVATED PROTEIN KINASE; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTAGLANDIN E2; PROTEIN KINASE C; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL PROLIFERATION; COLORECTAL CANCER; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; ENZYME ACTIVITY; FIBROBLAST; GENE OVEREXPRESSION; GENETIC TRANSCRIPTION; HALF LIFE TIME; NONHUMAN; PRIORITY JOURNAL; PROSTAGLANDIN RELEASE; PROTEIN EXPRESSION; PROTEIN SYNTHESIS INHIBITION; RAT; RNA STABILITY; STOMACH MUCOSA; TRANSACTIVATION; TRANSGENIC MOUSE;

3T3 CELLS; ANIMALS; CYCLOOXYGENASE 2; DINOPROSTONE; DRUG SYNERGISM; EPIDERMAL GROWTH FACTOR; FIBROBLASTS; GASTRINS; GENE EXPRESSION REGULATION; ISOENZYMES; MICE; MITOGEN-ACTIVATED PROTEIN KINASES; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; RECEPTOR, CHOLECYSTOKININ B; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTORS, CELL SURFACE; RECEPTORS, CHOLECYSTOKININ; RNA, MESSENGER; TRANSCRIPTION, GENETIC;

MUS MUSCULUS;

EID: 0042267991     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.10304     Document Type: Article

References (65)

1. Anderson GD, Hauser SD, McGarity KL, Bremer ME, Isakson PC, Gregory SA. 1996. Selective inhibition of cyclooxygenase (COX)-2 reverses inflammation and expression of COX-2 and interleukin 6 in rat adjuvant arthritis. J Clin Invest 97:2672-2679.
2. Baldwin GS, Shulkes A. 1998. Gastrin, gastrin receptors, and colorectal carcinoma. Gut 42:581-584.
3. Barnes CJ, Lee M. 1998. Chemoprevention of spontaneous intestinal adenomas in the adenomatous polyposis coli min mouse model with aspirin. Gastroenterology 114:873-877.
4. Barnes CJ, Cameron IL, Hardman WE, Lee M. 1998. Non-steroidol anti-inflammatory drug effect on crypt cell proliferation and apoptosis during initiation of rat colon carcinogenesis. Br J Cancer 77:573-580.
5. Carlsson E, Havu N, Mattsson H, Ekman L. 1990. Gastrin and gastric enterochromaffin-like cell carcinoids in the rat. Digestion 1 (Suppl 47): 17-23; discussion 49-52.
6. Chapple KS, Cartwright EJ, Hawcroft G, Tisbury A, Bonifer C, Scott N, Windsor AC, Guillou PJ, Markham AF, Coletta PL, Hull MA. 2000. Localization of cyclooxygenase-2 in human sporadic colorectal adenomas. Am J Pathol 156:545-553.
7. Covacci A, Telford JL, Del Giudice G, Parsonnet J, Rappuoli R. 1999. Helicobacter pylori virulence and genetic geography. Science 284: 1328-1333.
8. Daub H, Weiss FU, Wallasch C, Ullrich A. 1996. Role of transactivation of the EGF receptor in signalling by G-protein-coupled receptors. Nature 379:557-560.
9. DeWitt DL. 1991. Prostaglandin endoperoxide synthase: regulation of enzyme expression. Biochim Biophys Acta 1083:121-134.
10. Dixon DA, Kaplan CD, McIntyre TM, Zimmerman GA, Prescott SM. 2000. Post-transcriptional control of cyclooxygenase-2 gene expression. The role of the 3′-untranslated region. J Biol Chem 275:11750-11757.
11. Dubois RN, Abramson SB, Crofford L, Gupta RA, Simon LS, Van De Putte LB, Lipsky PE. 1998. Cyclooxygenase in biology and disease. FASEB J 12:1063-1073.
12. Eberhart CE, Dubois RN. 1995. Eicosanoids and the gastrointestinal tract. Gastroenterology 109:285-301.
13. Eberhart CE, Coffey RJ, Radhika A, Giardiello FM, Ferrenbach S, DuBois RN. 1994. Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology 107:1183-1188.
14. Ernst PB, Gold BD. 2000. The disease spectrum of Helicobacter pylori: The immunopathogenesis of gastroduodenal ulcer and gastric cancer. Annu Rev Microbiol 54:615-640.
15. Gou Q, Liu CH, Ben-Av P, Hla T. 1998. Dissociation of basal turnover and cytokine-induced transcript stabilization of the human cyclooxygenase-2 mRNA by mutagenesis of the 3′-untranslated region. Biochem Biophys Res Commun 242:508-512.
16. Greenberg ME, Bender TP. 1997. Identification of newly transscribed RNA. In: Ausubel FM, editor. Current protocols in molecular biology. New York: John Wiley & Sons, Inc. pp 4.10.1-4.10.11.
17. Guo YS, Cheng JZ, Jin GF, Gutkind JS, Hellmich MR, Townsend CM Jr. 2002. Gastrin stimulates cyclooxygenase-2 expression in intestinal epithelial cells through multiple signaling pathways. Evidence for involvement of ERK5 kinase and transactivation of EGF receptor. J Biol Chem 277:48755-48763.
18. Hartwich A, Konturek SJ, Pierzchalski P, Zuchowicz M, Labza H, Konturek PC, Karczewska E, Bielanski W, Marlicz K, Starzynska T, Lawniczak M, Hahn EG. 2001. Helicobacter pylori infection, gastrin, cyclooxygenase-2, and apoptosis in colorectal cancer. Int J Colorectal Dis 16:202-210.
19. Hecht JR, Duque J, Reddy ST, Herschman HR, Walsh JH, Slice LW. 1997. Gastrin-releasing peptide-induced expression of prostaglandin synthase-2 in Swiss 3T3 cells, Prostaglandins 54:757-768.
20. Hellmich MR, Rui XL, Hellmich HL, Fleming RY, Evers BM, Townsend CM Jr. 2000. Human colorectal cancers express a constitutively active cholecystokinin-B/gastrin receptor that stimulates cell growth. J Biol Chem 275:32122-32128.
21. Herschman HR, Kujubu DA, Fletcher BS, Ma Q, Varnum BC, Gilbert RS, Reddy ST. 1994. The tis genes, primary response genes induced by growth factors and tumor promoters in 3T3 cells. Prog Nucleic Acid Res Mol Biol 47:113-148.
22. Jang BC, Sanchez T, Schaefers HJ, Trifan OC, Liu CH, Creminon C, Huang CK, Hla T. 2000. Serum withdrawal-induced post-transcriptional stabilization of cyclooxygenase-2 mRNA in MDA-MB-231 mammary carcinoma cells requires the activity of the p38 stress-activated protein kinase. J Biol Chem 275:39507-39515.
23. Kinoshita Y, Nakata H, Kishi K, Kawanami C, Sawada M, Chiba T. 1998. Comparison of the signal transduction pathways activated by gastrin in enterochromaffin-like and parietal cells. Gastroenterology 115:93-100.
24. Komori M, Tsuji S, Sun WH, Tsujii M, Kawai N, Yasumaru M, Kakiuchi Y, Kimura A, Sasaki Y, Higashiyama S, Kawano S, Hori M. 2002. Gastrin enhances gastric mucosal integrity through cyclooxygenase-2 upregulation in rats. Am J Physiol Gastrointest Liver Physiol 283:G1368-G1378.
25. Konturek SJ, Konturek PC, Hartwich A, Hahn EG. 2000. Helicobacter pylori infection and gastrin and cyclooxygenase expression in gastric and colorectal malignancies. Regul Pept 93:13-19.
26. Konturek SJ, Konturek PC, Plonka A, Duda A, Sito E, Zuchowicz M, Hahn EG. 2001. Implication of gastrin in cyclooxygenase-2 expression in Helicobacter pylori infected gastric ulceration. Prostaglandins Other Lipid Mediat 66:39-51.
27. Levy GN. 1997. Prostaglandin H synthases, nonsteroidal antiinflammatory drugs, and colon cancer. FASEB J 11:234-247.
28. Lim RW, Varnum BC, Herschman HR. 1987. Cloning of tetradecanoyl phorbol ester-induced 'primary response' sequences and their expression in density-arrested Swiss 3T3 cells and a TPA nonproliferative variant. Oncogene 1:263-270.
29. Liu CH, Chang SH, Narko K, Trifan OC, Wu MT, Smith E, Haudenschild C, Lane TF, Hla T. 2001. Overexpression of cyclooxygenase-2 is sufficient to induce tumorigenesis in transgenic mice. J Biol Chem 276:18563-18569.
30. Marnett LJ, DuBois RN. 2002. COX-2: A target for colon cancer prevention. Annu Rev Pharmacol Toxicol 42:55-80.
31. McWilliams DF, Watson SA, Crosbee DM, Michaeli D, Seth R. 1998. Coexpression of gastrin and gastrin receptors (CCK-B and delta CCK-B) in gastrointestinal tumour cell lines. Gut 42:795-798.
32. Mehmet H, Millar JB, Lehmann W, Higgins T, Rozengurt E. 1990. Bombesin stimulation of c-fos expression and mitogenesis in Swiss 3T3 cells: The role of prostaglandin E2-mediated cyclic AMP accumulation. Exp Cell Res 190:265-270.
33. Nemeth J, Taylor B, Pauwels S, Varro A, Dockray GJ. 1993. Identification of progastrin derived peptides in colorectal carcinoma extracts. Gut 34:90-95.
34. Pai R, Soreghan B, Szabo IL, Pavelka M, Baatar D, Tarnawski AS. 2002. Prostaglandin E2 transactivates EGF receptor: A novel mechanism for promoting colon cancer growth and gastrointestinal hypertrophy. Nat Med 8:289-293.
35. Ristimaki A, Garfinkel S, Wessendorf J, Maciag T, Hla T. 1994. Induction of cyclooxygenase-2 by interleukin-1 alpha. Evidence for post-transcriptional regulation. J Biol Chem 269:11769-11775.
36. Ristimaki A, Honkanen N, Jankala H, Sipponen P, Harkonen M. 1997. Expression of cyclooxygenase-2 in human gastric carcinoma. Cancer Res 57:1276-1280.
37. Rozengurt E, Walsh JH. 2001. Gastrin, CCK, signaling, and cancer. Annu Rev Physiol 63:49-76.
38. Sawaoka H, Kawano S, Tsuji S, Tsujii M, Gunawan ES, Takei Y, Nagano K, Hori M. 1998. Cyclooxygenase-2 inhibitors suppress the growth of gastric cancer xenografts via induction of apoptosis in nude mice. Am J Physiol 274:G1061-G1067.
39. Shao J, Sheng H, Inoue H, Morrow JD, DuBois RN. 2000. Regulation of constitutive cyclooxygenase-2 expression in colon carcinoma cells. J Biol Chem 275:33951-33956.
40. Shattuck-Brandt RL, Varilek GW, Radhika A, Yang F, Washington MK, DuBois RN. 2000. Cyclooxygenase 2 expression is increased in the stroma of colon carcinomas from IL-10(-/-) mice. Gastroenterology 118:337-345.
41. Sheng H, Shao J, Kirkland SC, Isakson P, Coffey RJ, Morrow J, Beauchamp RD, DuBois RN. 1997. Inhibition of human colon cancer cell growth by selective inhibition of cyclooxygenase-2. J Clin Invest 99:2254-2259.
42. Sheng H, Shao J, Dixon DA, Williams CS, Prescott SM, DuBois RN, Beauchamp RD. 2000. Transforming growth factor-betal enhances Ha-ras-induced expression of cyclooxygenase-2 in intestinal epithelial cells via stabilization of mRNA. J Biol Chem 275:6628-6635.
43. Sheng H, Shao J, Dubois RN. 2001. K-Ras-mediated increase in cyclooxygenase 2 mRNA stability involves activation of the protein kinase B1. Cancer Res 61:2670-2675.
44. Slice LW, Walsh JH, Rozengurt E. 1999. Galpha(13) stimulates rho-dependent activation of the cyclooxygenase-2 promoter. J Biol Chem 274:27562-27566.
45. Slice LW, Bui L, Mak C, Walsh JH. 2000. Differential regulation of COX-2 transcription by ras- and rho-family of GTPases. Biochem Biophys Res Commun 276:406-410.
46. Slice LW, Han SK, Simon MI. 2003. Galphaq signaling is required for rho-dependent transcriptional activation of the cyclooxygenase-2 promoter in fibroblasts. J Cell Physiol 194:127-138.
47. Smith WL, Marnett LJ. 1991. Prostaglandin endoperoxide synthase: Structure and catalysis. Biochim Biophys Acta 1083:1-17.
48. Sobhani I, Lehy T, Laurent-Puig P, Cadiot G, Ruszniewski P, Mignon M. 1993. Chronic endogenous hypergastrinemia in humans: Evidence for a mitogenic effect on the colonic mucosa. Gastroenterology 105:22-30.
49. Solcia E, Rindi G, Paolotti D, La Rosa S, Capella C, Fiocca R. 1999. Clinicopathological profile as a basis for classification of the endocrine tumours of the gastroenteropancreatic tract. Ann Oncol 2(Suppl 10):S9-S15.
50. Stepan VM, Tatewaki M, Matsushima M, Dickinson CJ, del Valle J, Todisco A. 1999. Gastrin induces c-fos gene transcription via multiple signaling pathways. Am J Physiol 276:G415-G424.
51. Subbaramaiah K, Telang N, Ramonetti JT, Araki R, DeVito B, Weksler BB, Dannenberg AJ. 1996. Transcription of cyclooxygenase-2 is enhanced in transformed mammary epithelial cells. Cancer Res 56:4424-4429.
52. Svensson CI, Yaksh TL. 2002. The spinal phospholipase-cyclooxygenase-prostanoid cascade in nociceptive processing. Annu Rev Pharmacol Toxicol 42:553-583.
53. Taniguchi T, Matsui T, Ito M, Murayama T, Tsukamoto T, Katakami Y, Chiba T, Chihara K. 1994. Cholecystokinin-B/gastrin receptor signaling pathway involves tyrosine phosphorylations of p125FAK and p42MAP. Oncogene 9:861-867.
54. Thorburn CM, Friedman GD, Dickinson CJ, Vogelman JH, Orentreich N, Parsonnet J. 1998. Gastrin and colorectal cancer: A prospective study. Gastroenterology 115:275-280.
55. Todisco A, Takeuchi Y, Urumov A, Yamada J, Stepan VM, Yamada T. 1997. Molecular mechanisms for the growth factor action of gastrin. Am J Physiol 273:G891-G898.
56. Tsuji S, Sun WH, Tsujii M, Kawai N, Kimura A, Kakiuchi Y, Yasumaru S, Komori M, Murata H, Sasaki Y, Kawano S, Hori M. 2002. Lansoprazole induces mucosal protection through gastrin receptor-dependent up-regulation of cyclooxygenase-2 in rats. J Pharmacol Exp Ther 303:1301-1308.
57. Tsujii M, Kawano S, Tsuji S, Sawaoka H, Hori M, DuBois RN. 1998. Cyclooxygenase regulates angiogenesis induced by colon cancer cells. Cell 93:705-716.
58. Watson SA, Michaeli D, Grimes S, Morris TM, Robinson G, Varro A, Justin TA, Hardcastle JD. 1996. Gastrimmune raises antibodies that neutralize amidated and glycine-extended gastrin-17 and inhibit the growth of colon cancer. Cancer Res 56:880-885.
59. Watson SA, Michael D, Justin TA, Grimes S, Morris TM, Robinson G, Clarke PA, Hardcastle JD. 1998. Pre-clinical evaluation of the gastrimmune immunogen alone and in combination with 5-fluorouracil/leucovorin in a rat colorectal cancer model. Int J Cancer 75:873-877.
60. Xie W, Herschman HR. 1995. v-src induces prostaglandin synthase 2 gene expression by activation of the c-Jun N-terminal kinase and the c-Jun transcription factor. J Biol Chem 270:27622-27628.
61. Xie W, Herschman HR. 1996. Transcriptional regulation of prostaglandin synthase 2 gene expression by platelet-derived growth factor and serum. J Biol Chem 271:31742-31748.
62. Xie W, Fletcher BS, Andersen RD, Herschman HR. 1994. v-src induction of the TIS10/PGS2 prostaglandin synthase gene is mediated by an ATF/CRE transcription response element. Mol Cell Biol 14:6531-6539.
63. Yao M, Song DH, Rana B, Wolfe MM. 2002. COX-2 selective inhibition reverses the trophic properties of gastrin in colorectal cancer. Br J Cancer 87:574-579.
64. Zhang F, Subbaramaiah K, Altorki N, Dannenberg AJ. 1998. Dihydroxy bile acids activate the transcription of cyclooxygenase-2. J Biol Chem 273:2424-2428.
65. Zhukova E, Sinnett-Smith J, Wong H, Chiu T, Rozengurt E. 2001. CCK(B)/gastrin receptor mediates synergistic stimulation of DNA synthesis and cyclin D1, D3, and E expression in Swiss 3T3 cells. J Cell Physiol 189:291-305.